Cargando…
Immune cell landscape and immunotherapy of medulloblastoma
Medulloblastoma is the most common primary pediatric malignancy of the central nervous system. Recurrent and refractory patients account for approximately 30% of them. Immune cells are an important component of the brain tumor microenvironment, including tumor‐associated macrophages, T lymphocytes,...
Autores principales: | Zhang, Jin, Wang, Tianyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666938/ https://www.ncbi.nlm.nih.gov/pubmed/34938973 http://dx.doi.org/10.1002/ped4.12261 |
Ejemplares similares
-
Cellular immunotherapy for medulloblastoma
por: Schakelaar, Michael Y, et al.
Publicado: (2022) -
Immunotherapy for Medulloblastoma: Current Perspectives
por: Kabir, Tanvir F, et al.
Publicado: (2020) -
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Kim, Myung-Chul, et al.
Publicado: (2021) -
The transcriptional landscape of Shh medulloblastoma
por: Skowron, Patryk, et al.
Publicado: (2021) -
In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)